Skip to main content
SpringerLink
Log in

Therapy for the Brugada Syndrome

  • Chapter
Basis and Treatment of Cardiac Arrhythmias

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 171))

Abstract

The Brugada syndrome is a congenital syndrome of sudden cardiac death first described as a new clinical entity in 1992. Electrocardiographically characterized by a distinct coved-type ST segment elevation in the right precordial leads, the syndrome is associated with a high risk for sudden cardiac death in young and otherwise healthy adults, and less frequently in infants and children. The ECG manifestations of the Brugada syndrome are often dynamic or concealed and may be revealed or modulated by sodium channel blockers. The syndrome may also be unmasked or precipitated by a febrile state, vagotonic agents, α-adrenergic agonists, β-adrenergic blockers, tricyclic or tetracyclic antidepressants, a combination of glucose and insulin, and hypokalemia, as well as by alcohol and cocaine toxicity. An implantable cardioverter-defibrillator (ICD) is the most widely accepted approach to therapy. Pharmacological therapy aimed at rebalancing the currents active during phase 1 of the right ventricular action potential is used to abort electrical storms, as an adjunct to device therapy, and as an alternative to device therapy when use of an ICD is not possible. Isoproterenol and cilostazol boost calcium channel current, and drugs like quinidine inhibit the transient outward current, acting to diminish the action potential notch and thus suppress the substrate and trigger for ventricular tachycardia/fibrillation (VT/VF).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 389.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 499.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alings M, Wilde A (1999) “Brugada” syndrome: clinical data and suggested pathophysiological mechanism. Circulation 99:666–673

    CAS  PubMed  Google Scholar 

  • Alings M, Dekker L, Sadee A, Wilde A (2001) Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol 24:1420–1422

    Article  CAS  PubMed  Google Scholar 

  • Antzelevitch C (2001a) The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 12:268–272

    Article  CAS  PubMed  Google Scholar 

  • Antzelevitch C (2001b) The Brugada syndrome. Diagnostic criteria and cellular mechanisms. Eur Heart J 22:356–363

    Article  CAS  PubMed  Google Scholar 

  • Antzelevitch C, Brugada R (2002) Fever and the Brugada syndrome. Pacing Clin Electrophysiol 25:1537–1539

    Article  PubMed  Google Scholar 

  • Antzelevitch C, Shimizu W (2002) Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol 17:43–51

    Article  PubMed  Google Scholar 

  • Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, Di Diego JM, Gintant GA, Liu DW (1991) Heterogeneity within the ventricular wall: electrophysiology and pharmacology of epicardial, endocardial and M cells. Circ Res 69:1427–1449

    CAS  PubMed  Google Scholar 

  • Antzelevitch C, Brugada P, Brugada J, Brugada R, Nademanee K, Towbin JA (1999a) The Brugada syndrome. In: Camm AJ (ed) Clinical approaches to tachyarrhythmias. Futura Publishing Company, Armonk, pp 1–99

    Google Scholar 

  • Antzelevitch C, Shimizu W, Yan GX, Sicouri S, Weissenburger J, Nesterenko VV, Burashnikov A, Di Diego JM, Saffitz JE, Thomas GP (1999b) The M cell: Its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 10:1124–1152

    CAS  PubMed  Google Scholar 

  • Antzelevitch C, Brugada P, Brugada J, Brugada R, Shimizu W, Gussak I, Perez Riera AR (2002) Brugada syndrome: a decade of progress. Circ Res 91:1114–1118

    Article  CAS  PubMed  Google Scholar 

  • Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Riera ARP, Tan H, Shimizu W, Schulze-Bahr E, Wilde A (2005) Brugada syndrome. Report of the Second Consensus Conference. Circulation 111:659–670

    Article  PubMed  Google Scholar 

  • Araki T, Konno T, Itoh H, Ino H, Shimizu M (2003) Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia. Circ J 67:93–95

    Article  PubMed  Google Scholar 

  • Ayerza MR, de Zutter M, Goethals M, Wellens F, Geelen P, Brugada P (2002) Heart transplantation as last resort against Brugada syndrome. J Cardiovasc Electrophysiol 13:943–944

    Article  PubMed  Google Scholar 

  • Babaliaros VC, Hurst JW (2002) Tricyclic antidepressants and the Brugada syndrome: an example of Brugada waves appearing after the administration of desipramine. Clin Cardiol 25:395–398

    PubMed  Google Scholar 

  • Balser JR (2001) The cardiac sodium channel: gating function and molecular pharmacology. J Mol Cell Cardiol 33:599–613

    Article  CAS  PubMed  Google Scholar 

  • Belardinelli L, Antzelevitch C, Vos MA (2003) Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci 24:619–625

    Article  CAS  PubMed  Google Scholar 

  • Belhassen B, Viskin S (2004) Pharmacologic approach to therapy of Brugada syndrome: quinidine as an alternative to ICD therapy? In: Antzelevitch C, Brugada P, Brugada J, Brugada R (eds) The Brugada syndrome: from bench to bedside. Blackwell Futura, Oxford, pp 202–211

    Google Scholar 

  • Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M (1999) Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome [see comments]. J Cardiovasc Electrophysiol 10:1301–1312

    CAS  PubMed  Google Scholar 

  • Belhassen B, Viskin S, Antzelevitch C (2002) The Brugada syndrome: is ICD the only therapeutic option? Pacing Clin Electrophysiol 25:1634–1640

    Article  PubMed  Google Scholar 

  • Bezzina C, Veldkamp MW, van Den Berg MP, Postma AV, Rook MB, Viersma JW, Van Langen IM, Tan-Sindhunata G, Bink-Boelkens MT, Der Hout AH, Mannens MM, Wilde AA (1999) A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res 85:1206–1213

    CAS  PubMed  Google Scholar 

  • Bolognesi R, Tsialtas D, Vasini P, Conti M, Manca C (1997) Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose. Am J Cardiol 79:242–245

    Article  CAS  PubMed  Google Scholar 

  • Bordachar P, Reuter S, Garrigue S, Cai X, Hocini M, Jais P, Haissaguerre M, Clementy J (2004) Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J 25:879–884

    Article  PubMed  Google Scholar 

  • Brugada J, Brugada R, Brugada P (1998) Right bundle-branch block and ST-segment elevation in leads V1 through V3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 97:457–460

    CAS  PubMed  Google Scholar 

  • Brugada J, Brugada R, Brugada P (2000a) Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden death. J Electrocardiol 33 Suppl:41–47

    Article  PubMed  Google Scholar 

  • Brugada P, Brugada R, Brugada J, Geelen P (1999) Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts. Am J Cardiol 83:98D–100D

    Article  CAS  PubMed  Google Scholar 

  • Brugada P, Brugada J, Brugada R (2000b) Arrhythmia induction by antiarrhythmic drugs. Pacing Clin Electrophysiol 23:291–292

    CAS  PubMed  Google Scholar 

  • Brugada P, Brugada R, Antzelevitch C, Nademanee K, Towbin J, Brugada J (2003) The Brugada syndrome. In: Gussak I, Antzelevitch C (eds) Cardiac repolarization. bridging basic and clinical sciences. Humana Press, Totowa, pp 427–446

    Google Scholar 

  • Brugada P, Bartholomay E, Mont L, Brugada R, Brugada J (2004) Treatment of Brugada syndrome with an implantable cardioverter defibrillator. In: Antzelevitch C, Brugada P, Brugada J, Brugada R (eds) The Brugada syndrome: from bench to bedside. Blackwell Futura, Oxford, pp 194–201

    Google Scholar 

  • Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P (2000c) Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101:510–515

    CAS  PubMed  Google Scholar 

  • Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O’Brien RE, Schultze-Bahr E, Keating MT, Towbin JA, Wang Q (1998) Genetic basis andmolecular mechanisms for idiopathic ventricular fibrillation. Nature 392:293–296

    Article  CAS  PubMed  Google Scholar 

  • Chinushi M, Aizawa Y, Ogawa Y, Shiba M, Takahashi K (1997) Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome. J Electrocardiol 30:133–136

    Article  CAS  PubMed  Google Scholar 

  • Di Diego JM, Cordeiro JM, Goodrow RJ, Fish JM, Zygmunt AC, Perez GJ, Scornik FS, Antzelevitch C (2002) Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 106:2004–2011

    Article  PubMed  Google Scholar 

  • Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko VV, Nesterenko DV, Brugada J, Brugada R, Antzelevitch C (1999) Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 85:803–809

    CAS  PubMed  Google Scholar 

  • Dzielinska Z, Bilinska ZT, Szumowski L, Grzybowski J, Michalak E, Przybylski A, Lubiszewska B, Walczak F, Ruzyllo W (2004) [Recurrent ventricular fibrillation during a febrile illness as the first manifestation of Brugada syndrome—a case report]. Kardiol Pol 61:269–273

    PubMed  Google Scholar 

  • Eckardt L, Kirchhof P, Johna R, Haverkamp W, Breithardt G, Borggrefe M (2001) Wolff-Parkinson-White syndrome associated with Brugada syndrome. Pacing Clin Electrophysiol 24:1423–1424

    Article  CAS  PubMed  Google Scholar 

  • Fish JM, Antzelevitch C (2004) Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 1:210–217

    Article  PubMed  Google Scholar 

  • Fish JM, Extramiana F, Antzelevitch C (2004a) AVE0118, an Ito and IKur blocker, suppresses VT/VF in an experimental model of the Brugada syndrome. Circulation 110:III–193 (abstr)

    Article  Google Scholar 

  • Fish JM, Extramiana F, Antzelevitch C (2004b) Tedisamil abolishes the arrhythmogenic substrate responsible for VT/VF in an experimental model of the Brugada syndrome. Heart Rhythm 1:S158 (abstr)

    Article  Google Scholar 

  • Fujiki A, Usui M, Nagasawa H, Mizumaki K, Hayashi H, Inoue H (1999) ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome [see comments]. J Cardiovasc Electrophysiol 10:214–218

    CAS  PubMed  Google Scholar 

  • Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C, Simonini S (2003) Flecainide test in Brugada syndrome: a reproducible but risky tool. Pacing Clin Electrophysiol 26:338–341

    Article  PubMed  Google Scholar 

  • Goldgran-Toledano D, Sideris G, Kevorkian JP (2002) Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 346:1591–1592

    Article  PubMed  Google Scholar 

  • Gonzalez Rebollo G, Madrid H, Carcia A, Garcia de Casto A, Moro AM (2000) Recurrent ventricular fibrillation during a febrile illness in a patient with the Brugada syndrome. Rev Esp Cardiol 53:755–757

    CAS  PubMed  Google Scholar 

  • Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR (1999) The Brugada syndrome: clinical, electrophysiological and genetic aspects. J Am Coll Cardiol 33:5–15

    Article  CAS  PubMed  Google Scholar 

  • Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera JA, Farre G, Leenhardt A, Sanders P, Scavee C, Hsu LF, Weerasooriya R, Shah DC, Frank R, Maury P, Delay M, Garrigue S, Clementy J (2003) Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 108:925–928

    Article  PubMed  Google Scholar 

  • Hermida JS, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, Guicheney P, Di Fusco S, Rey JL, Cauchemez B, Leenhardt A (2004) Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol 43:1853–1860

    Article  CAS  PubMed  Google Scholar 

  • Hong K, Berruezo-Sanchez A, Poungvarin N, Oliva A, Vatta M, Brugada J, Brugada P, Towbin JA, Dumaine R, Pinero-Galvez C, Antzelevitch C, Brugada R (2004) Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A. J Cardiovasc Electrophysiol 15:64–69

    PubMed  Google Scholar 

  • Horigome H, Shigeta O, Kuga K, Isobe T, Sakakibara Y, Yamaguchi I, Matsui A (2003) Ventricular fibrillation during anesthesia in association with J waves in the left precordial leads in a child with coarctation of the aorta. J Electrocardiol 36:339–343

    Article  PubMed  Google Scholar 

  • Kalla H, Yan GX, Marinchak R (2000) Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: a Brugada syndrome variant? J Cardiovasc Electrophysiol 11:95–98

    CAS  PubMed  Google Scholar 

  • Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, Shoda M, Toyoshima Y, Hosoda S (1997) Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 95:2277–2285

    CAS  PubMed  Google Scholar 

  • Kies P, Wichter T, Schafers M, Paul M, Schafers KP, Eckardt L, Stegger L, Schulze-Bahr E, Rimoldi O, Breithardt G, Schober O, Camici PG (2004) Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome1. Circulation 110: 3017–3022

    Article  CAS  PubMed  Google Scholar 

  • Krishnan SC, Antzelevitch C (1991) Sodium channel blockade produces opposite electrophysiologic effects in canine ventricular epicardium and endocardium. Circ Res 69:277–291

    CAS  PubMed  Google Scholar 

  • Krishnan SC, Antzelevitch C (1993) Flecainide-induced arrhythmia in canine ventricular epicardium: phase 2 reentry? Circulation 87:562–572

    CAS  PubMed  Google Scholar 

  • Krishnan SC, Josephson ME (1998) ST segment elevation induced by class IC antiarrhythmic agents: underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia. J Cardiovasc Electrophysiol 9:1167–1172

    CAS  PubMed  Google Scholar 

  • Kum L, Fung JWH, Chan WWL, Chan GK, Chan YS, Sanderson JE (2002) Brugada syndrome unmasked by febrile illness. Pacing Clin Electrophysiol 25:1660–1661

    Article  PubMed  Google Scholar 

  • Kurita T, Shimizu W, Inagaki M, Suyama K, Taguchi A, Satomi K, Aihara N, Kamakura S, Kobayashi J, Kosakai Y (2002) The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 40:330–334

    Article  PubMed  Google Scholar 

  • Litovsky SH, Antzelevitch C (1990) Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. Circ Res 67:615–627

    CAS  PubMed  Google Scholar 

  • Littmann L, Monroe MH, Svenson RH (2000) Brugada-type electrocardiographic pattern induced by cocaine. Mayo Clin Proc 75:845–849

    Article  CAS  PubMed  Google Scholar 

  • Lukas A, Antzelevitch C (1996) Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. The antiarrhythmic effects of 4-aminopyridine. Cardiovasc Res 32:593–603

    Article  CAS  PubMed  Google Scholar 

  • Madle A, Kratochvil Z, Polivkova A (2002) [The Brugada syndrome]. Vnitr Lek 48:255–258

    CAS  PubMed  Google Scholar 

  • Matana A, Goldner V, Stanic K, Mavric Z, Zaputovic L, Matana Z (2000) Unmasking effect of propafenone on the concealed form of the Brugada phenomenon. Pacing Clin Electrophysiol 23:416–418

    CAS  PubMed  Google Scholar 

  • Matsuo K, Shimizu W, Kurita T, Inagaki M, Aihara N, Kamakura S (1998) Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 9:508–512

    CAS  PubMed  Google Scholar 

  • Miyasaka Y, Tsuji H, Yamada K, Tokunaga S, Saito D, Imuro Y, Matsumoto N, Iwasaka T (2001) Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol 38:771–774

    Article  CAS  PubMed  Google Scholar 

  • Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S (1996) Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 27:1061–1070

    Article  CAS  PubMed  Google Scholar 

  • Mizumaki K, Fujiki A, Tsuneda T, Sakabe M, Nishida K, Sugao M, Inoue H (2004) Vagal activity modulates spontaneous augmentation of ST elevation in daily life of patients with Brugada syndrome. J Cardiovasc Electrophysiol 15:667–673

    Article  PubMed  Google Scholar 

  • Mok NS, Chan NY, Chi-Suen CA (2004) Successful use of quinidine in treatment of electrical storm in Brugada syndrome. Pacing Clin Electrophysiol 27:821–823

    Article  PubMed  Google Scholar 

  • Morita H, Kusano-Fukushima K, Nagase S, Fujimoto Y, Hisamatsu K, Fujio H, Haraoka K, Kobayashi M, Morita ST, Nakamura K, Emori T, Matsubara H, Hina K, Kita T, Fukatani M, Ohe T (2002) Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol 40:1437

    Article  PubMed  Google Scholar 

  • Morita H, Fukushima-Kusano K, Nagase S, Miyaji K, Hiramatsu S, Banba K, Nishii N, Watanabe A, Kakishita M, Takenaka-Morita S, Nakamura K, Saito H, Emori T, Ohe T (2004) Sinus node function in patients with Brugada-type ECG. Circ J 68:473–476

    Article  PubMed  Google Scholar 

  • Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, Tunsanga K, Kuasirikul S, Malasit P, Tansupasawadikul S, Tatsanavivat P (1997) Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 96:2595–2600

    CAS  PubMed  Google Scholar 

  • Nimmannit S, Malasit P, Chaovakul V, Susaengrat W, Vasuvattakul S, Nilwarangkur S (1991) Pathogenesis of sudden unexplained nocturnal death (lai tai) and endemic distal renal tubular acidosis. Lancet 338:930–932

    Article  CAS  PubMed  Google Scholar 

  • Noda T, Shimizu W, Taguchi A, Satomi K, Suyama K, Kurita T, Aihara N, Kamakura S (2002) ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome. J Am Coll Cardiol 40:1841–1847

    Article  PubMed  Google Scholar 

  • Nogami A, Nakao M, Kubota S, Sugiyasu A, Doi H, Yokoyama K, Yumoto K, Tamaki T, Kato K, Hosokawa N, Sagai H, Nakamura H, Nitta J, Yamauchi Y, Aonuma K (2003) Enhancement of J-ST-segment elevation by the glucose and insulin test in Brugada syndrome. Pacing Clin Electrophysiol 26:332–337

    Article  PubMed  Google Scholar 

  • Ortega-Carnicer J, Bertos-Polo J, Gutierrez-Tirado C (2001) Aborted sudden death, transient Brugada pattern, and wide QRS dysrhythmias after massive cocaine ingestion. J Electrocardiol 34:345–349

    Article  CAS  PubMed  Google Scholar 

  • Ortega-Carnicer J, Benezet J, Ceres F (2003) Fever-induced ST-segment elevation and T-wave alternans in a patient with Brugada syndrome. Resuscitation 57:315–317

    Article  PubMed  Google Scholar 

  • Pastor A, Nunez A, Cantale C, Cosio FG (2001) Asymptomatic Brugada syndrome case unmasked during dimenhydrinate infusion. J Cardiovasc Electrophysiol 12:1192–1194

    Article  CAS  PubMed  Google Scholar 

  • Pitzalis MV, Anaclerio M, Iacoviello M, Forleo C, Guida P, Troccoli R, Massari F, Mastropasqua F, Sorrentino S, Manghisi A, Rizzon P (2003) QT-interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome. J Am Coll Cardiol 42:1632–1637

    Article  PubMed  Google Scholar 

  • Porres JM, Brugada J, Urbistondo V, Garcia F, Reviejo K, Marco P (2002) Fever unmasking the Brugada syndrome. Pacing Clin Electrophysiol 25:1646–1648

    Article  PubMed  Google Scholar 

  • Potet F, Mabo P, Le Coq G, Probst V, Schott JJ, Airaud F, Guihard G, Daubert JC, Escande D, Le Marec H (2003) Novel Brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads. J Cardiovasc Electrophysiol 14:200–203

    Article  PubMed  Google Scholar 

  • Priori SG, Napolitano C, Gasparini M, Pappone C, Della BP, Brignole M, Giordano U, Giovannini T, Menozzi C, Bloise R, Crotti L, Terreni L, Schwartz PJ (2000) Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 102:2509–2515

    CAS  PubMed  Google Scholar 

  • Priori SG, Napolitano C, Gasparini M, Pappone C, Della BP, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J (2002) Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105:1342–1347

    Article  PubMed  Google Scholar 

  • Proclemer A, Facchin D, Feruglio GA, Nucifora R (1993) Recurrent ventricular fibrillation, right bundle-branch block and persistent ST segment elevation in V1-V3: a new arrhythmia syndrome? A clinical case report [see comments]. G Ital Cardiol 23:1211–1218

    CAS  PubMed  Google Scholar 

  • Rolf S, Bruns HJ, Wichter T, Kirchhof P, Ribbing M, Wasmer K, Paul M, Breithardt G, Haverkamp W, Eckardt L (2003) The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. Eur Heart J 24:1104–1112

    Article  CAS  PubMed  Google Scholar 

  • Rouleau F, Asfar P, Boulet S, Dube L, Dupuis JM, Alquier P, Victor J (2001) Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome. J Cardiovasc Electrophysiol 12:61–65

    Article  CAS  PubMed  Google Scholar 

  • Sangwatanaroj S, Prechawat S, Sunsaneewitayakul B, Sitthisook S, Tosukhowong P, Tungsanga K (2001) New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J 22:2290–2296

    Article  CAS  PubMed  Google Scholar 

  • Saura D, Garcia-Alberola A, Carrillo P, Pascual D, Martinez-Sanchez J, Valdes M (2002) Brugada-like electrocardiographic pattern induced by fever. Pacing Clin Electrophysiol 25:856–859

    Article  PubMed  Google Scholar 

  • Shimizu W (2004) Acquired forms of Brugada syndrome. In: Antzelevitch C, Brugada P, Brugada J, Brugada R (eds) The Brugada syndrome: from bench to bedside. Blackwell Futura, Oxford, pp 166–177

    Google Scholar 

  • Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, Takaki H, Sunagawa K, Kamakura S (2000a) Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 11:1320–1329

    Article  CAS  PubMed  Google Scholar 

  • Shimizu W, Matsuo K, Takagi M, Tanabe Y, Aiba T, Taguchi A, Suyama K, Kurita T, Aihara N, Kamakura S (2000b) Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 11:396–404

    Article  CAS  PubMed  Google Scholar 

  • Shimizu W, Aiba T, Kurita T, Kamakura S (2001) Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. J Cardiovasc Electrophysiol 12:1418–1421

    Article  CAS  PubMed  Google Scholar 

  • Smits JP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA, Haverkamp W, Breithardt G, Escande D, Schulze-Bahr E, LeMarec H, Wilde AA (2002) Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 40:350–356

    Article  CAS  PubMed  Google Scholar 

  • Suzuki H, Torigoe K, Numata O, Yazaki S (2000) Infant case with a malignant form of Brugada syndrome. J Cardiovasc Electrophysiol 11:1277–1280

    Article  CAS  PubMed  Google Scholar 

  • Tada H, Nogami A, Shimizu W, Naito S, Nakatsugawa M, Oshima S, Taniguchi K (2000) ST segment and T wave alternans in a patient with Brugada syndrome. Pacing Clin Electrophysiol 23:413–415

    CAS  PubMed  Google Scholar 

  • Tada H, Sticherling C, Oral H, Morady F (2001) Brugada syndrome mimicked by tricyclic antidepressant overdose. J Cardiovasc Electrophysiol 12:275

    Article  CAS  PubMed  Google Scholar 

  • Takehara N, Makita N, Kawabe J, Sato N, Kawamura Y, Kitabatake A, Kikuchi K (2004) A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J Intern Med 255:137–142

    Article  CAS  PubMed  Google Scholar 

  • Takenaka S, Emori T, Koyama S, Morita H, Fukushima K, Ohe T (1999) Asymptomatic form of Brugada syndrome. Pacing Clin Electrophysiol 22:1261–1263

    CAS  PubMed  Google Scholar 

  • Tan HL, Bezzina CR, Smits JP, Verkerk AO, Wilde AA (2003) Genetic control of sodium channel function. Cardiovasc Res 57:961–973

    Article  CAS  PubMed  Google Scholar 

  • Tanaka H, Kinoshita O, Uchikawa S, Kasai H, Nakamura M, Izawa A, Yokoseki O, Kitabayashi H, Takahashi W, Yazaki Y, Watanabe N, Imamura H, Kubo K (2001) Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin Electrophysiol 24:1293–1294

    Article  CAS  PubMed  Google Scholar 

  • Tsuchiya T, Ashikaga K, Honda T, Arita M (2002) Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 13:698–701

    Article  PubMed  Google Scholar 

  • van Den Berg MP, Wilde AA, Viersma TJW, Brouwer J, Haaksma J, van der Hout AH, Stolte-Dijkstra I, Bezzina TCR, Van Langen IM, Beaufort-Krol GC, Cornel JH, Crijns HJ (2001) Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol 12:630–636

    Article  PubMed  Google Scholar 

  • Vatta M, Dumaine R, Varghese G, Richard TA, Shimizu W, Aihara N, Nademanee K, Brugada R, Brugada J, Veerakul G, Li H, Bowles NE, Brugada P, Antzelevitch C, Towbin JA (2002) Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 11:337–345

    Article  CAS  PubMed  Google Scholar 

  • Weiss R, Barmada MM, Nguyen T, Seibel JS, Cavlovich D, Kornblit CA, Angelilli A, Villanueva F, McNamara DM, London B (2002) Clinical and molecular heterogeneity in the Brugada syndrome. A novel gene locus on chromosome 3. Circulation 105:707–713

    Article  CAS  PubMed  Google Scholar 

  • Wichter T, Matheja P, Eckardt L, Kies P, Schafers K, Schulze-Bahr E, Haverkamp W, Borggrefe M, Schober O, Breithardt G, Schafers M (2002) Cardiac autonomic dysfunction in Brugada syndrome. Circulation 105:702–706

    Article  PubMed  Google Scholar 

  • Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA (2002a) Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 106:2514–2519

    Article  PubMed  Google Scholar 

  • Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA (2002b) Proposed diagnostic criteria for the Brugada syndrome: consensus report. Eur Heart J 23:1648–1654

    CAS  PubMed  Google Scholar 

  • Yan GX, Antzelevitch C (1996) Cellular basis for the electrocardiographic J wave. Circulation 93:372–379

    CAS  PubMed  Google Scholar 

  • Yan GX, Antzelevitch C (1999) Cellular basis for the Brugada Syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 100:1660–1666

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Masonic Medical Research Laboratory, 2150 Bleecker Street, Utica, NY, 13501, USA

    C. Antzelevitch & J.M. Fish

Authors
  1. C. Antzelevitch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J.M. Fish
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Antzelevitch, C., Fish, J. (2006). Therapy for the Brugada Syndrome. In: Basis and Treatment of Cardiac Arrhythmias. Handbook of Experimental Pharmacology, vol 171. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29715-4_12

Download citation

Publish with us

Policies and ethics

Search

Navigation